Clinical trial
Isopropyl Alcohol Inhalation as Anti-emetic Therapy in the Emergency Department
NCT04464915 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Isopropyl Alcohol Inhalation as Anti-emetic Therapy in the Emergency Department
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- July 31, 2020
- Completion date
- November 30, 2020
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.